Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1)
1_MTDDN 6_ SDDKI 11_ EDELQ 16_ TFFTS 21_ DKDGN 26_ THAYN 31_ PKSPP 36_ TQNSS 41_ ASSVN 46_ WNSAN 51_ PDDMV 56_ VDYET 61_ DPAVV 66_ TGENI 71_ SLSLQ 76_ GVEVF 81_ GHEKS 86_ SSDFI 91_ SKQVL 96_ DMHKD 101_ SICQC 106_ PALVG 111_ TEKPK 116_ YLQHS 121_ CHSLE 126_ AVEGQ 131_ SVEPS 136_ LPFVW 141_ KPNDN 146_ LNCAG 151_ YCDAL 156_ ELNQT 161_ FDMTV 166_ DKVNC 171_ TFISH 176_ HAIGK 181_ SQSFH 186_ TAGSL 191_ PPTGR 196_ RSGST 201_ SSLSY 206_ STWTS 211_ SHSDK 216_ THARE 221_ TTYDR 226_ ESFEN 231_ PQVTP 236_ SEAQD 241_ MTYTA 246_ FSDVV 251_ MQSEV 256_ FVSDI 261_ GNQCA 266_ CSSGK 271_ VTSEY 276_ TDGSQ 281_ QRLVG 286_ EKETQ 291_ ALTPV 296_ SDGME 301_ VPNDS 306_ ALQEF 311_ FCLSH 316_ DESNS 321_ EPHSQ 326_ SSYRH 331_ KEMGQ 336_ NLRET 341_ VSYCL 346_ IDDEC 351_ PLMVP 356_ AFDKS 361_ EAQVL 366_ NPEHK 371_ VTETE 376_ DTQMV 381_ SKGKD 386_ LGTQN 391_ HTSEL 396_ ILSSP 401_ PGQKV 406_ GSSFG 411_ LTWDA 416_ NDMVI 421_ STDKT 426_ MCMST 431_ PVLEP 436_ TKVTF 441_ SVSPI 446_ EATEK 451_ CKKVE 456_ KGNRG 461_ LKNIP 466_ DSKEA 471_ PVNLC 476_ KPSLG 481_ KSTIK 486_ TNTPI 491_ GCKVR 496_ KTEII 501_ SYPRP 506_ NFKNV 511_ KAKVM 516_ SRAVL 521_ QPKDA 526_ ALSKV 531_ TPRPQ 536_ QTSAS 541_ SPSSV 546_ NSRQQ 551_ TVLSR 556_ TPRSD 561_ LNADK 566_ KAEIL 571_ INKTH 576_ KQQFN 581_ KLITS 586_ QAVHV 591_ TTHSK 596_ NASHR 601_ VPRTT 606_ SAVKS 611_ NQEDV 616_ DKASS 621_ SNSAC 626_ ETGSV 631_ SALFQ 636_ KIKGI 641_ LPVKM 646_ ESAEC 651_ LEMTY 656_ VPNID 661_ RISPE 666_ KKGEK 671_ ENGTS 676_ MEKQE 681_ LKQEI 686_ MNETF 691_ EYGSL 696_ FLGSA 701_ SKTTT 706_ TSGRN 711_ ISKPD 716_ SCGLR 721_ QIAAP 726_ KAKVG 731_ PPVSC 736_ LRRNS 741_ DNRNP 746_ SADRA 751_ VSPQR 756_ IRRVS 761_ SSGKP 766_ TSLKT 771_ AQSSW 776_ VNLPR 781_ PLPKS 786_ KASLK 791_ SPALR 796_ RTGST 801_ PSIAS 806_ THSEL 811_ STYSN 816_ NSGNA 821_ AVIKY 826_ EEKPP 831_ KPAFQ 836_ NGSSG 841_ SFYLK 846_ PLVSR 851_ AHVHL 856_ MKTPP 861_ KGPSR 866_ KNLFT 871_ ALNAV 876_ EKSRQ 881_ KNPRS 886_ LCIQP 891_ QTAPD 896_ ALPPE 901_ KTLEL 906_ TQYKT 911_ KCENQ 916_ SGFIL 921_ QLKQL 926_ LACGN 931_ TKFEA 936_ LTVVI 941_ QHLLS 946_ EREEA 951_ LKQHK 956_ TLSQE 961_ LVNLR 966_ GELVT 971_ ASTTC 976_ EKLEK 981_ ARNEL 986_ QTVYE 991_ AFVQQ 996_ HQAEK 1001_ TEREN 1006_ RLKEF 1011_ YTREY 1016_ EKLRD 1021_ TYIEE 1026_ AEKYK 1031_ MQLQE 1036_ QFDNL 1041_ NAAHE 1046_ TSKLE 1051_ IEASH 1056_ SEKLE 1061_ LLKKA 1066_ YEASL 1071_ SEIKK 1076_ GHEIE 1081_ KKSLE 1086_ DLLSE 1091_ KQESL 1096_ EKQIN 1101_ DLKSE 1106_ NDALN 1111_ EKLKS 1116_ EEQKR 1121_ RAREK 1126_ ANLKN 1131_ PQIMY 1136_ LEQEL 1141_ ESLKA 1146_ VLEIK 1151_ NEKLH 1156_ QQDIK 1161_ LMKME 1166_ KLVDN 1171_ NTALV 1176_ DKLKR 1181_ FQQEN 1186_ EELKA 1191_ RMDKH 1196_ MAISR 1201_ QLSTE 1206_ QAVLQ 1211_ ESLEK 1216_ ESKVN 1221_ KRLSM 1226_ ENEEL 1231_ LWKLH 1236_ NGDLC 1241_ SPKRS 1246_ PTSSA 1251_ IPLQS 1256_ PRNSG 1261_SFPSP
1: Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation. Isoform 1 inhibits breast cancer cell proliferation, delays the progression of mitosis by prolonging metaphase and reduces tumor growth